- Home
- OXM vs PRTA Comparison
OXM vs PRTA Comparison
Compare OXM & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OXM | PRTA |
|---|---|---|
| Founded | 1942 | 2012 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 482.3M |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OXM | PRTA |
|---|---|---|
| Price | $37.94 | $9.81 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $44.80 | $19.00 |
| AVG Volume (30 Days) | 209.9K | ★ 383.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.36% | N/A |
| EPS Growth | ★ 53.66 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,516,601,000.00 | $814,000.00 |
| Revenue This Year | N/A | $1,111.38 |
| Revenue Next Year | $1.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.57 | $4.32 |
| 52 Week High | $64.39 | $14.60 |
Technical Indicators
Market Signals| Indicator | OXM | PRTA |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 57.58 |
| Support Level | $35.48 | $9.54 |
| Resistance Level | $42.12 | $10.72 |
| Average True Range (ATR) | 1.80 | 0.57 |
| MACD | -0.26 | 0.12 |
| Stochastic Oscillator | 30.02 | 77.97 |
Price Performance
Historical ComparisonAbout OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.